1.Overlooked or not been considered. Either way, why?
2. Considered but offer declined. If so, it would have been announced unless PH shut it down at first contact.
3. If 2 applies AZ would have found ways to get what it wants.
Therefore 1. the most likely reason. USD 150m for an OV said to be likely one way to cure cancer, 2 B-Cell vaxx that revolutionized the check point inhibitor field and an allo CAR-T that most likely will be the first one to be approved - and yet, not even a tiny pharma wants all that.
Either they are all idiots or what we've been told doesn't measure up. And no, AICp, waiting for ph 1b / 2 / 3 data is not the reason.
IMU Price at posting:
3.4¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)